730 likes | 2.04k Views
NEOPLASIA. Dr G R Wright School of Pathology Division of Anatomical Pathology University of the Witwatersrand. Neoplasia. Epithelial lesions Connective tissue lesions Tumours of childhood Effects of tumours / Paraneoplastic syndromes Pathology of Chemotherapy / Irradiation.
E N D
NEOPLASIA Dr G R Wright School of Pathology Division of Anatomical Pathology University of the Witwatersrand
Neoplasia Epithelial lesions Connective tissue lesions Tumours of childhood Effects of tumours / Paraneoplastic syndromes Pathology of Chemotherapy / Irradiation
Effects of Tumours • Depends on the SITE, NATURE and SIZE of the individual tumour • LOCAL and GENERALISED effects • PARANEOPLASTIC SYNDROMES
Local effects • BENIGN TUMOURS: • Pressure / Obstruction • Functional Activity • Local Anatomical Complications • Torsion, infection, haemorrhage, ulceration • Malignant Transformation
Local Effects • MALIGNANT TUMOUS: • Pressure / Obstruction • Destruction of Tissue • Local Anatomical Complications • Ulceration, haemorrhage, infection • Pain
Generalised Effects • Starvation • Cachexia • Fever • Haematological Changes • Immunological Effects • Hormone production More pronounced with malignant tumours
Paraneoplastic Syndromes • Collection of symptoms that can not be explained by the growth of the tumour • Clinical importance: • First manifestation of malignancy • Significant morbidity • Mimic metastatic disease
Paraneoplastic Syndromes • Divided into: • Endocrinopathies • Nerve and muscle syndromes • Dermatological disorders • Osseous, articular and soft tissue changes • Vascular and haematological changes
Endocrinopathies • Hormone / Hormone-like substance produced by cells that are not of endocrine origin • Cushing syndrome • Hypercalcaemia • Carcinoid syndrome • Polycythaemia • Hypoglycaemia
Cushing Syndrome • ACTH or ACTH-like substance • Small cell carcinoma of lung • Pancreatic carcinoma • Neural tumours
Carcinoid Syndrome • Excessive serotonin production • Neuroendocrine tumours • Clinical features: • Vasomotor disturbances (flushing) • Intestinal hypermotility (cramps, diarrhoea) • Bronchoconstriction • Systemic fibrosis
Myasthenia • ? Immunological • Bronchogenic carcinomas • Weakness, ± autonomic dysfunction
AcanthosisNigricans • ? Epidermal growth factors from tumours • Gastric, lung & uterine carcinomas • Middle aged-elderly adults • Flexures
AcanthosisNigricans Velvety hyperpigmented Acanthosis
Dermatomyositis • Immunological • Bronchogenic and breast carcinoma • Rashes & muscle weakness
Hypertrophic osteoarthropathy • Cause unknown • Bronchogenic carcinoma • Features: • Periosteal new bone formation • Arthritis of adjacent joints • Clubbing
Hypertrophic osteoarthropathy Clubbing
Venous Thrombosis • Trousseau phenomenon • Pro-coagulatory products of tumours • Pancreatic & bronchogenic carcinoma
Nonbacterial Thrombotic Endocarditis • Hypercoagulability • Advanced mucin secreting adenocarcinoma • Bland small fibrinous vegetations on valves (L>R)
Radiation • Electromagnetic waves and particles • 80% from natural sources – UV light, cosmic radiation, radioisotopes • 20% manufactured – instruments, nuclear power plants • Effects dependant on dose and timing of exposure • Causes acute and chronic effects
Radiation • NON-IONISING RADIATION • Long wavelength, low frequency • Electricity, radio waves, microwaves, infrared, UV • IONISING RADIATION • Short wavelength, high frequency • Xrays, gamma rays, cosmic radiation • PARTICULATE – alpha and beta particles, protone, mesons,deutrons
Radiation Effects • Dependant on: • Dose rate • Whole body vs focal & fractionated • Rapidly dividing cells are more radiosensitive than quiescent cells • Cells in G2 or Mitoses are most sensitive • Different cells have different repairative responses
Mechanisms of Cellular Damage • Ionization • Production of free radicals • DNA Damage • Strand breaks – multiple double strand • Base alterations – mutations • Cross-linking – replication prevented
Tissue SensitivityDirectly proportional to rate of cell division: • HIGH • Haemopoietic tissue • Lymphoid tissue • Gonads • Intestinal mucosa • MEDIUM • Liver • Pancreas • Endocrine glands • Connective tissues • LOW • Heart muscle • Skeletal muscle • Nerve cells • Brain • Mature bone • Mature cartilage
Effects on Cells • Immediate death • Prevention of further division→ apoptosis • Change in genotype – mutation • Repair
Blood vessels • Endothelial damage and loss • Exposure of collagen • Thrombosis and necrosis • Endothelial and intimal proliferation • Telangiectasis • Endarteritis obliterans
Bone Marrow • Suspends renewal of all 3 cell lines • Time to decrease in blood counts dependant on physiological survival of cells • Whole body – marrow failure • Localised – marrow fibrosis
Gastro-intestinal Mucosa • Nausea, vomiting, diarrhoea → dehydration, electrolyte abnormalities • Ulceration • Haemorrhage • Secondary infection • Stricture, obstruction
Other tissues • Skin • Erythema, desquamation, ulceration → dermal fibrosis • Gonads • Sterility • Germ cell mutation → foetal abnormalities • Follicular cell damage in ovary → artificial menopause • Lung • Rich blood supply • ARDS / DAD → alveolar fibrosis • Kidney • Loss of parenchyma → decreased renal function ± hypertension
Whole Body Irradiation • Effects depend on dose • Cerebral syndrome • Drowsiness, convulsions, coma • Hours post exposure • Gastro-intestinal syndrome • Vomiting, diarrhoea→ Ulceration, haemorrhage, infection • Days post exposure • Haemopoietic syndrome • Leucocytopaenia, thrombocytopaenia→ infection , haemorrhage • Weeks post exposure
Ultraviolet Radiation • Associated with squamous cell carcinoma, basal cell carcinoma, melanoma, etc • Three types • UVA • Inhibits DNA repair • UVB • Non-ionising – DNA strand linkage • UVC • Filtered out by ozone layer • Very toxic
Radiotherapy • Some tumours more sensitive than others • Localised tumour – cure • Disseminated disease – palliative relief of symptoms eg pain and pressure effects • Used in combination with surgery / chemotherapy • Fractionation • Normal tissue - attempt repair between doses • More of tumour cells to enter cell cycle
Chemotherapy • Pathology depends on class of drug • Classes • DNA damaging – free radicals, cross linking • DNA repair inhibitors • Antimetabolites • Antitubulin
Chemotherapy • Side effects: • Nausea, vomiting • Hair loss • Myelosuppression • Myositis • Organ specific toxicity (lung, heart, liver) • Sterility • Secondary malignancies
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage ARDS = Clinical dx DAD = Histological dx Diffuse alveolar infiltrate on CXR
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage • Causes: • Infections eg. sepsis, TB • Physical / Injury eg trauma, drowning • Inhaled irritants eg smoke • Chemical injury eg chemotherapy - Bleomycin • Haematological conditions eg DIC • Pancreatitis • Ureamia • Hypersensitivity reactions
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage • Bleomycin: • Antibiotic • Glycopeptide • Pulmonary toxicity dependant on • Age • Dose • Duration
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage ACUTE: Heavy Firm Red / Congested Boggy
Normal Lung Airway Vein Alveoli Inter-alveolar septum Artery
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage Acute Phase Congestion Interstitial oedema Intra-alveolar oedema, inflammation and fibrin deposition
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage Hyaline membranes Pneumocyte type II proliferation and atypia
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage Chronic Phase Organisation → Fibrosis Thickening of inter- alveolar septae
Adult Respiratory Distress Syndrome / Diffuse Alveolar Damage • Pathogenesis: • End result of alveolar injury due to different mechanisms • Damage to alveolar capillary endothelium or alveolar epithelium • → Inflammatory process
Cardiotoxicity • NB – Adriamycin (Doxorubicin) • Dilated cardiomyopathy - Progressive cardiac dilation and contractile dysfunction • Risk factors: • Age • Mediastinal DXT • Combination therapy • Pre-existing cardiac pathology • Dose intervals & total dose
Dilated cardiomyopathy CXR Normal CXR
Dilated Cardiomyopathy Thin wall